Potent antibody therapeutics by design

被引:833
作者
Carter, PJ [1 ]
机构
[1] Genet Incorp, Dept Antibody Technol, Bothell, WA 98021 USA
关键词
D O I
10.1038/nri1837
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I review here, is an iterative design process that involves the generation and optimization of antibodies to improve their clinical potential.
引用
收藏
页码:343 / 357
页数:15
相关论文
共 144 条
[51]   Engineered antibody fragments and the rise of single domains [J].
Holliger, P ;
Hudson, PJ .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1126-1136
[52]   Retargeting serum immunoglobulin with bispecific diabodies [J].
Holliger, P ;
Wing, M ;
Pound, JD ;
Bohlen, H ;
Winter, G .
NATURE BIOTECHNOLOGY, 1997, 15 (07) :632-636
[53]   Selecting and screening recombinant antibody libraries [J].
Hoogenboom, HR .
NATURE BIOTECHNOLOGY, 2005, 23 (09) :1105-1116
[54]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
[55]   Immunogenicity of engineered antibodies [J].
Hwang, WYK ;
Foote, J .
METHODS, 2005, 36 (01) :3-10
[56]   Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc [J].
Idusogie, EE ;
Presta, LG ;
Gazzano-Santoro, H ;
Totpal, K ;
Wong, PY ;
Ultsch, M ;
Meng, YG ;
Mulkerrin, MG .
JOURNAL OF IMMUNOLOGY, 2000, 164 (08) :4178-4184
[57]   Engineered antibodies with increased activity to recruit complement [J].
Idusogie, EE ;
Wong, PY ;
Presta, LG ;
Gazzano-Santoro, H ;
Totpal, K ;
Ultsch, M ;
Mulkerrin, MG .
JOURNAL OF IMMUNOLOGY, 2001, 166 (04) :2571-2575
[58]  
Illert B, 2005, ONCOL REP, V13, P765
[59]   Aggregation-resistant domain antibodies selected on phage by heat denaturation [J].
Jespers, L ;
Schon, O ;
Famm, K ;
Winter, G .
NATURE BIOTECHNOLOGY, 2004, 22 (09) :1161-1165
[60]   REPLACING THE COMPLEMENTARITY-DETERMINING REGIONS IN A HUMAN-ANTIBODY WITH THOSE FROM A MOUSE [J].
JONES, PT ;
DEAR, PH ;
FOOTE, J ;
NEUBERGER, MS ;
WINTER, G .
NATURE, 1986, 321 (6069) :522-525